1-10 of 10
Anna M. Liberati
Close
Sort by
Journal Articles

Met Over-Expression Is a Prognostic Factor for Myeloma Patients Treated with Novel Agents.

Albero Rocci, MD, Francesca Gay, MD, Livio Trusolino, MD, Paola Omedè, PhD, Andrea Bertotti, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Giuseppe Rossi, MD, Daniela Drandi, PhD, Paolo Corradini, MD, Marco Ladetto, MD, Paolo M. Comoglio, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 1821.
https://doi.org/10.1182/blood.V114.22.1821.1821
Published: 2009
Journal Articles

Bortezomib-Doxorubicin-Dexamethasone as Induction Prior to Reduced Intensity Autologous Transplantation Followed by Lenalidomide as Consolidation/Maintenance in Elderly Untreated Myeloma Patients

Antonio Palumbo, MD, Patrizia Falco, MD, Francesca Gay, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Federica Cavallo, MD, Paolo Corradini, MD, Giuseppe Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2008) 112 (11): 159.
https://doi.org/10.1182/blood.V112.11.159.159
Published: 2008
Journal Articles

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Clinical Trials & Observations
Antonio Palumbo, Sara Bringhen, Anna M. Liberati, Tommaso Caravita, Antonietta Falcone, Vincenzo Callea, Marco Montanaro, Roberto Ria, Antonio Capaldi, Renato Zambello, Giulia Benevolo, Daniele Derudas, Fausto Dore, Federica Cavallo, Francesca Gay, Patrizia Falco, Giovannino Ciccone, Pellegrino Musto, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2008) 112 (8): 3107–3114.
https://doi.org/10.1182/blood-2008-04-149427
Published: 2008
Journal Articles

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Clinical Trials & Observations
Marco Ladetto, Federica De Marco, Fabio Benedetti, Umberto Vitolo, Caterina Patti, Alessandro Rambaldi, Alessandro Pulsoni, Maurizio Musso, Anna M. Liberati, Attilio Olivieri, Andrea Gallamini, Enrico Pogliani, Delia Rota Scalabrini, Vincenzo Callea, Francesco Di Raimondo, Vincenzo Pavone, Alessandra Tucci, Sergio Cortelazzo, Alessandro Levis, Mario Boccadoro, Ignazio Majolino, Alessandro Pileri, Alessandro M. Gianni, Roberto Passera, Paolo Corradini, Corrado Tarella
Journal: Blood
Blood (2008) 111 (8): 4004–4013.
https://doi.org/10.1182/blood-2007-10-116749
Published: 2008
Journal Articles

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Marco Ladetto, MD, Federica De Marco, MD, Fabio Benedetti, MD, Umberto Vitolo, MD, Caterina Patti, MD, Alessandro Rambaldi, MD, Alessandro Pulsoni, MD, Maurizio Musso, MD, Anna M. Liberati, MD, Attilio Olivieri, MD, Andrea Gallamini, MD, Enrico Pogliani, MD, Delia Rota Scalabrini, MD, Vincenzo Callea, MD, Francesco Di Raimondo, MD, Vincenzo Pavone, MD, Alessandra Tucci, MD, Sergio Cortelazzo, MD, Alessandro Levis, MD, Mario Boccadoro, MD, Ignazio Majolino, MD, Alessandro Pileri, MD, Alessandro M. Gianni, MD, Roberto Passera, PhD, Paolo Corradini, MD, Corrado Tarella, MD
Journal: Blood
Blood (2007) 110 (11): 20.
https://doi.org/10.1182/blood.V110.11.20.20
Published: 2007
Journal Articles

Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m 2 in Elderly Newly Diagnosed Patients: An Interim Analysis.

Antonio Palumbo, MD, Ilaria Avonto, MD, Francesca Patriarca, MD, Claudia Crippa, MD, Maria T. Petrucci, MD, Fausto Rossini, MD, Paolo Corradini, MD, Anna M. Liberati, MD, Nicola Giuliani, MD, Norbert Pescosta, MD, Patrizia Falco, MD, Alessandra Larocca, MD, Paola Omedè, MD, Massimo Offidani, MD, Renato Fanin, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 448.
https://doi.org/10.1182/blood.V110.11.448.448
Published: 2007
Journal Articles

A Continous Recurrent Course in a Case of Nodular-Sclerosis (NS) Classical Hodgkin’s Lymphoma (cHL) Associated with Castleman’s Disease (CD).

Annamaria Rauco, Fabrizio Liberati, Rosanna Capozzi, Maria G. Morandi, Roberta Pace, Vincenzo Capparella, Michele Cianciulli, Anna M. Liberati
Journal: Blood
Blood (2005) 106 (11): 4824.
https://doi.org/10.1182/blood.V106.11.4824.4824
Published: 2005
Journal Articles

Ph’-Positive (Ph’+) Chronic Myeloid Leukemia (CML) Presenting as Ph’+ T-Lymphoblastic Lymphoma (LL) Resistant to High-Dose Chemotherapy and Gleevec.

Lorenzo Falchi, Giorgia Desantis, Fabrizio Liberati, Roberta Pace, Maria G. Morandi, Patrizia Scaravaglio, Giuseppe Saglio, Anna M. Liberati
Journal: Blood
Blood (2005) 106 (11): 4869.
https://doi.org/10.1182/blood.V106.11.4869.4869
Published: 2005
Journal Articles

Molecular Response of CML Patients to INFα Based Treatment or to STI Based Therapy.

Debora Luzi, Rosanna Capozzi, Annamaria Rauco, Roberta Pace, Emilio Donti, Enrico Gottardi, Alessandra Bassetti, Monica Schippa, Giuseppe Saglio, Anna M. Liberati
Journal: Blood
Blood (2005) 106 (11): 4872.
https://doi.org/10.1182/blood.V106.11.4872.4872
Published: 2005
Journal Articles

Has the 67 Ga-SPET a Role in Monitoring Hodgkin and Primary Mediastinal Lymphoma in the PET-FDG Age?.

Isabella Palumbo, Giorgia Desantis, Barbara Palumbo, Lorenzo Falchi, Paola Cerroni, Vincenzo Capparella, Michele Cianciulli, Renato Palumbo, Anna M. Liberati
Journal: Blood
Blood (2005) 106 (11): 4643.
https://doi.org/10.1182/blood.V106.11.4643.4643
Published: 2005